FI20020197A0 - Yhdistelmä akuutin myokardiilisen infarktin hoitoon - Google Patents

Yhdistelmä akuutin myokardiilisen infarktin hoitoon

Info

Publication number
FI20020197A0
FI20020197A0 FI20020197A FI20020197A FI20020197A0 FI 20020197 A0 FI20020197 A0 FI 20020197A0 FI 20020197 A FI20020197 A FI 20020197A FI 20020197 A FI20020197 A FI 20020197A FI 20020197 A0 FI20020197 A0 FI 20020197A0
Authority
FI
Finland
Prior art keywords
myocardial infarction
acute myocardial
treatment method
combination treatment
combination
Prior art date
Application number
FI20020197A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Pentti Pader
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20020197A priority Critical patent/FI20020197A0/fi
Publication of FI20020197A0 publication Critical patent/FI20020197A0/fi
Priority to NZ534221A priority patent/NZ534221A/xx
Priority to ES03700828T priority patent/ES2249707T3/es
Priority to JP2003563560A priority patent/JP2005516050A/ja
Priority to MXPA04007345A priority patent/MXPA04007345A/es
Priority to DE60301862T priority patent/DE60301862T2/de
Priority to BR0307317-3A priority patent/BR0307317A/pt
Priority to SI200330113T priority patent/SI1478362T1/sl
Priority to PCT/FI2003/000078 priority patent/WO2003063870A1/en
Priority to DK03700828T priority patent/DK1478362T3/da
Priority to EP03700828A priority patent/EP1478362B1/en
Priority to AU2003201980A priority patent/AU2003201980B2/en
Priority to CA2474430A priority patent/CA2474430C/en
Priority to PL371741A priority patent/PL212241B1/pl
Priority to AT03700828T priority patent/ATE306267T1/de
Priority to US10/502,981 priority patent/US20050255096A1/en
Priority to CNB038030918A priority patent/CN1291718C/zh
Priority to IL163091A priority patent/IL163091A/en
Priority to ZA200406085A priority patent/ZA200406085B/en
Priority to HK05109333A priority patent/HK1077215A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
FI20020197A 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon FI20020197A0 (fi)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon
CNB038030918A CN1291718C (zh) 2002-02-01 2003-01-31 一种用于治疗急性心肌梗死的药物产品
PCT/FI2003/000078 WO2003063870A1 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction
EP03700828A EP1478362B1 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction
JP2003563560A JP2005516050A (ja) 2002-02-01 2003-01-31 急性心筋梗塞のための複合治療
MXPA04007345A MXPA04007345A (es) 2002-02-01 2003-01-31 Un tratamiento en combinacion para infarto agudo al miocardio.
DE60301862T DE60301862T2 (de) 2002-02-01 2003-01-31 Kombinationsbehandlung bei akutem myokardinfarkt
BR0307317-3A BR0307317A (pt) 2002-02-01 2003-01-31 Tratamento de combinação para infartação miocardial aguda
SI200330113T SI1478362T1 (sl) 2002-02-01 2003-01-31 Kombinacijsko zdravljenje pri akutnem miokardnem infarktu
NZ534221A NZ534221A (en) 2002-02-01 2003-01-31 A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
DK03700828T DK1478362T3 (da) 2002-02-01 2003-01-31 Kombinationsbehandling til akut myokardisk infarkt
ES03700828T ES2249707T3 (es) 2002-02-01 2003-01-31 Tratameinto de combinacion para infarto de miocardio agudo.
AU2003201980A AU2003201980B2 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction
CA2474430A CA2474430C (en) 2002-02-01 2003-01-31 A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
PL371741A PL212241B1 (pl) 2002-02-01 2003-01-31 Złożony produkt leczniczy i jego zastosowanie
AT03700828T ATE306267T1 (de) 2002-02-01 2003-01-31 Kombinationsbehandlung bei akutem myokardinfarkt
US10/502,981 US20050255096A1 (en) 2002-02-01 2003-01-31 Combination treatment for acute myocardial infarction
IL163091A IL163091A (en) 2002-02-01 2004-07-19 Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction
ZA200406085A ZA200406085B (en) 2002-02-01 2004-07-29 A combination treatment for acute myocardial infarction.
HK05109333A HK1077215A1 (en) 2002-02-01 2005-10-20 A pharmaceutical composition for treatment of acute myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon

Publications (1)

Publication Number Publication Date
FI20020197A0 true FI20020197A0 (fi) 2002-02-01

Family

ID=8563019

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon

Country Status (19)

Country Link
US (1) US20050255096A1 (es)
EP (1) EP1478362B1 (es)
JP (1) JP2005516050A (es)
CN (1) CN1291718C (es)
AT (1) ATE306267T1 (es)
AU (1) AU2003201980B2 (es)
BR (1) BR0307317A (es)
CA (1) CA2474430C (es)
DE (1) DE60301862T2 (es)
DK (1) DK1478362T3 (es)
ES (1) ES2249707T3 (es)
FI (1) FI20020197A0 (es)
HK (1) HK1077215A1 (es)
IL (1) IL163091A (es)
MX (1) MXPA04007345A (es)
NZ (1) NZ534221A (es)
PL (1) PL212241B1 (es)
WO (1) WO2003063870A1 (es)
ZA (1) ZA200406085B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
US20070010518A1 (en) * 2005-02-18 2007-01-11 Matti Kivikko Method for administering levosimendan
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
WO2008082871A1 (en) * 2006-12-28 2008-07-10 Orion Corporation Formulations of levosimendan for parenteral administration
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5626601A (en) * 1995-10-27 1997-05-06 Gary Gershony Vascular sealing apparatus and method
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5463564A (en) * 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties

Also Published As

Publication number Publication date
WO2003063870A1 (en) 2003-08-07
NZ534221A (en) 2007-06-29
MXPA04007345A (es) 2004-11-26
CN1291718C (zh) 2006-12-27
PL371741A1 (en) 2005-06-27
IL163091A (en) 2012-06-28
CN1625398A (zh) 2005-06-08
CA2474430C (en) 2010-09-28
ES2249707T3 (es) 2006-04-01
BR0307317A (pt) 2005-01-04
PL212241B1 (pl) 2012-08-31
DK1478362T3 (da) 2005-11-14
CA2474430A1 (en) 2003-08-07
ATE306267T1 (de) 2005-10-15
HK1077215A1 (en) 2006-02-10
EP1478362B1 (en) 2005-10-12
JP2005516050A (ja) 2005-06-02
DE60301862T2 (de) 2006-07-20
US20050255096A1 (en) 2005-11-17
AU2003201980B2 (en) 2006-12-07
EP1478362A1 (en) 2004-11-24
DE60301862D1 (de) 2006-02-23
ZA200406085B (en) 2005-10-06

Similar Documents

Publication Publication Date Title
CY1121113T1 (el) Θεραπεια της νοσου ρομρε
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
DK1173178T3 (da) Præparat, der omfatter apomorfin og sildenafil, og anvendelse deraf til behandling af erektil dysfunktion
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
NO20032027D0 (no) Effektive antitumorbehandlinger
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
PT1039900E (pt) Agentes terapeuticos
FI20011464A0 (fi) Yhdistelmäterapia sydämen vajaatoiminnan hoitoon
TW200509909A (en) Use of organic compounds
DE60111622D1 (de) Getrennte dosis therapien mit gefässschädigender aktivität
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
RU2002117537A (ru) Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
NO20043774L (no) The use of devazenide as analgesic agent
CO5170404A1 (es) Terapia para melanomas